Physician profile
Fatima Ezzeddine
NPI 1881046894
$11,706.04
in general payments reported to CMS, 2019-2025
9 companies · $3,096 in 2025
The $3,096 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $25.43 · 2022: $69.71 · 2023: $4,040 · 2024: $4,322 · 2025: $3,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,105 · Food and Beverage: $3,205 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,104.81 |
| Food and Beverage | $3,204.94 |
| Education | $148.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,667.14 | 2023-2025 | Advisa Dr Mri Surescan, Micra, Amplia Mri Quad Crt-D Surescan |
| Philips North America LLC | $3,224.92 | 2023-2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, (5028) Igt Devices Systems Undivided |
| Abbott Laboratories | $2,685.35 | 2022-2025 | Ensite Precision, Ensite |
| Medical Device Business Services, INC. | $1,786.81 | 2024 | Carto 3 |
| Boston Scientific Corporation | $123.76 | 2025 | General - Ep |
| Abiomed | $101.34 | 2020 | |
| Getinge USA Sales, LLC | $50.96 | 2020 | |
| Biosense Webster, INC. | $40.33 | 2024 | Qdot Micro Catheter |
| Biotronik INC. | $25.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fatima Ezzeddine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.